3 Vaccine Candidates In Advanced Stage Of Clinical Trials: Centre
India News | Press Trust of India | Saturday September 19, 2020
Three of the nearly 30 coronavirus vaccine candidates in the country are in advanced stages of clinical trials, while four are in pre-clinical development stage, Science and Technology Ministry Harsh Vardhan said on Friday.
India News | Friday September 18, 2020
India added 96,424 coronavirus infections in 24 hours, taking its tally past the 52-lakh mark, the Health Ministry data this morning showed.
US Plans To Distribute Covid Vaccine Immediately After Authorization
World News | Reuters | Wednesday September 16, 2020
The U.S. government on Wednesday said it will start distributing a COVID-19 vaccine within one day of regulatory authorization as it plans for the possibility that a limited number of vaccine doses may be available at the end of the year.
Government Backing 30 Covid Vaccine Candidates, Parliament Told
India News | Written by Neeta Sharma | Wednesday September 16, 2020
More than 30 vaccines under trial have been supported by the government and three of them are in advance stages, the home ministry told parliament on Wednesday. Four of these are at an advanced pre-clinical development stage, the government said.
Russia To Sell 100 Million Doses Of Sputnik-V Vaccine To Dr Reddy's Lab
India News | Reuters | Wednesday September 16, 2020
Russia's sovereign wealth fund has said it will supply India's Dr Reddy's Laboratories with 100 million doses of the Sputnik-V vaccine against COVID-19 once it receives regulatory approval in the country.
Trump Says Coronavirus Vaccine Could Be Ready In A Month
World News | Agence France-Presse | Wednesday September 16, 2020
President Donald Trump said Tuesday that a coronavirus vaccine may be available within a month -- an acceleration of even his own surprisingly optimistic predictions -- but added that the pandemic could go away by itself.
Serum Institute Gets Nod To Resume Oxford COVID-19 Vaccine Trial In India
India News | Press Trust of India | Wednesday September 16, 2020
Drugs Controller General of India (DCGI) Dr VG Somani on Tuesday gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country while revoking its earlier order of suspending any new recruitment for phase two and three trial.
US Firm Novavax Aims For 2 Billion COVID Vaccine Doses With Expanded India Deal
World News | Reuters | Tuesday September 15, 2020
US drug developer Novavax said on Tuesday it was doubling its potential COVID-19 vaccine manufacturing capacity to two billion doses annually under an agreement with Serum Institute of India, sending its shares up about 7%.
Phase 1 Trials Of 2 Covid Vaccines Reveal "Excellent Safety": Minister
India News | Press Trust of India | Tuesday September 15, 2020
Phase-I clinical trials have revealed "excellent safety" of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with ICMR and Cadila Healthcare Ltd and their immunogenicity testing is now in progress, Minister of State for Health Ashwini Choubey informed the Rajya Sabha on Tuesday.
China Coronavirus Vaccine May Be Ready For Public In November: Official
World News | Reuters | Tuesday September 15, 2020
Coronavirus vaccines being developed in China may be ready for use by the general public as early as November, an official with the China Centre for Disease Control and Prevention (CDC) said.
Coronavirus India Live Updates: COVID-19 Cases Cross 49 Lakh-Mark
India News | Edited by Nonika Marwaha | Tuesday September 15, 2020
Coronavirus Latest Updates: With 83,809 cases has push India's coronavirus tally to 49,30,237 the Union Health Ministry data this morning showed. The death count has risen to 80,776 with 1,054 more fatalities.
UAE Allows Health Staff To Take Emergency Covid Vaccine Still Under Trial
World News | Reuters | Monday September 14, 2020
The United Arab Emirates on Monday granted emergency approval for use of a coronavirus vaccine, six weeks after human trials in the Gulf Arab state started.
WHO Head Urges Rich Nations To Join Vaccine Scheme By Friday Deadline
World News | Reuters | Monday September 14, 2020
Countries should join the World Health Organization's (WHO) COVAX vaccine facility by a Friday deadline to help ensure that immunizations are fairly and efficiently distributed, WHO Director General Tedros Adhanom Ghebreyesus said on Monday.
UK Reserves Up To 190 million Doses Of Potential Coronavirus Vaccines
World News | Agence France-Presse | Monday September 14, 2020
Britain has secured access to up to 190 million doses of a potential coronavirus vaccine from Valneva in deal worth as much as 1.37 billion euros, the French-Austrian vaccine firm said Monday.
Sensex Jumps Over 300 Points, Nifty Crosses 11,500 Amid Gains Across Sectors
Business | Edited by Sandeep Singh (with inputs from agencies) | Monday September 14, 2020
Share Market Updates: Asian share markets firmed on renewed hopes for a coronavirus vaccine after AstraZeneca resumed its Phase 3 trial.
3 Vaccine Candidates In Advanced Stage Of Clinical Trials: Centre
India News | Press Trust of India | Saturday September 19, 2020
Three of the nearly 30 coronavirus vaccine candidates in the country are in advanced stages of clinical trials, while four are in pre-clinical development stage, Science and Technology Ministry Harsh Vardhan said on Friday.
India News | Friday September 18, 2020
India added 96,424 coronavirus infections in 24 hours, taking its tally past the 52-lakh mark, the Health Ministry data this morning showed.
US Plans To Distribute Covid Vaccine Immediately After Authorization
World News | Reuters | Wednesday September 16, 2020
The U.S. government on Wednesday said it will start distributing a COVID-19 vaccine within one day of regulatory authorization as it plans for the possibility that a limited number of vaccine doses may be available at the end of the year.
Government Backing 30 Covid Vaccine Candidates, Parliament Told
India News | Written by Neeta Sharma | Wednesday September 16, 2020
More than 30 vaccines under trial have been supported by the government and three of them are in advance stages, the home ministry told parliament on Wednesday. Four of these are at an advanced pre-clinical development stage, the government said.
Russia To Sell 100 Million Doses Of Sputnik-V Vaccine To Dr Reddy's Lab
India News | Reuters | Wednesday September 16, 2020
Russia's sovereign wealth fund has said it will supply India's Dr Reddy's Laboratories with 100 million doses of the Sputnik-V vaccine against COVID-19 once it receives regulatory approval in the country.
Trump Says Coronavirus Vaccine Could Be Ready In A Month
World News | Agence France-Presse | Wednesday September 16, 2020
President Donald Trump said Tuesday that a coronavirus vaccine may be available within a month -- an acceleration of even his own surprisingly optimistic predictions -- but added that the pandemic could go away by itself.
Serum Institute Gets Nod To Resume Oxford COVID-19 Vaccine Trial In India
India News | Press Trust of India | Wednesday September 16, 2020
Drugs Controller General of India (DCGI) Dr VG Somani on Tuesday gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country while revoking its earlier order of suspending any new recruitment for phase two and three trial.
US Firm Novavax Aims For 2 Billion COVID Vaccine Doses With Expanded India Deal
World News | Reuters | Tuesday September 15, 2020
US drug developer Novavax said on Tuesday it was doubling its potential COVID-19 vaccine manufacturing capacity to two billion doses annually under an agreement with Serum Institute of India, sending its shares up about 7%.
Phase 1 Trials Of 2 Covid Vaccines Reveal "Excellent Safety": Minister
India News | Press Trust of India | Tuesday September 15, 2020
Phase-I clinical trials have revealed "excellent safety" of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with ICMR and Cadila Healthcare Ltd and their immunogenicity testing is now in progress, Minister of State for Health Ashwini Choubey informed the Rajya Sabha on Tuesday.
China Coronavirus Vaccine May Be Ready For Public In November: Official
World News | Reuters | Tuesday September 15, 2020
Coronavirus vaccines being developed in China may be ready for use by the general public as early as November, an official with the China Centre for Disease Control and Prevention (CDC) said.
Coronavirus India Live Updates: COVID-19 Cases Cross 49 Lakh-Mark
India News | Edited by Nonika Marwaha | Tuesday September 15, 2020
Coronavirus Latest Updates: With 83,809 cases has push India's coronavirus tally to 49,30,237 the Union Health Ministry data this morning showed. The death count has risen to 80,776 with 1,054 more fatalities.
UAE Allows Health Staff To Take Emergency Covid Vaccine Still Under Trial
World News | Reuters | Monday September 14, 2020
The United Arab Emirates on Monday granted emergency approval for use of a coronavirus vaccine, six weeks after human trials in the Gulf Arab state started.
WHO Head Urges Rich Nations To Join Vaccine Scheme By Friday Deadline
World News | Reuters | Monday September 14, 2020
Countries should join the World Health Organization's (WHO) COVAX vaccine facility by a Friday deadline to help ensure that immunizations are fairly and efficiently distributed, WHO Director General Tedros Adhanom Ghebreyesus said on Monday.
UK Reserves Up To 190 million Doses Of Potential Coronavirus Vaccines
World News | Agence France-Presse | Monday September 14, 2020
Britain has secured access to up to 190 million doses of a potential coronavirus vaccine from Valneva in deal worth as much as 1.37 billion euros, the French-Austrian vaccine firm said Monday.
Sensex Jumps Over 300 Points, Nifty Crosses 11,500 Amid Gains Across Sectors
Business | Edited by Sandeep Singh (with inputs from agencies) | Monday September 14, 2020
Share Market Updates: Asian share markets firmed on renewed hopes for a coronavirus vaccine after AstraZeneca resumed its Phase 3 trial.
................................ Advertisement ................................
................................ Advertisement ................................
